Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Welch

Showing results (781-790 of 803) with videos related to

Pageof 81
Sort By:
Journal of Medicinal Chemistry|March 28, 1997
Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonistsW C Patt, J J Edmunds, J T Repine, et al.
Human Molecular Genetics|March 3, 2016
Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophyXin Zhao, Zhihua Feng, Karen K Y Ling, et al.
The Science of the Total Environment|May 1, 2022
Associations between social, biologic, and behavioral factors and biomarkers of oxidative stress during pregnancy: Findings from four ECHO cohortsStephanie M Eick, Sarah Dee Geiger, Akram Alshawabkeh, et al.
Plos One|October 16, 2010
Iridovirus and microsporidian linked to honey bee colony declineJerry J Bromenshenk, Colin B Henderson, Charles H Wick, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 18, 2022
Catchment Profile of Large Cochlear Implant Centers in the United StatesAshley M Nassiri, Meredith A Holcomb, Elizabeth L Perkins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2024
Preclinical studies of gene replacement therapy for CDKL5 deficiency disorderGregory Voronin, Jana Narasimhan, Jamila Gittens, et al.
Chemical Biology & Drug Design|June 22, 2007
Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitorsChad A Van Huis, Christopher F Bigge, Agustin Casimiro-Garcia, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory CytokinesJeremy Luban, Rachel Sattler, Elke Mühlberger, et al.
Virus Research|November 29, 2020
The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokinesJeremy Luban, Rachel A Sattler, Elke Mühlberger, et al.
Chemical Biology & Drug Design|August 9, 2007
The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitorJeffrey T Kohrt, Christopher F Bigge, John W Bryant, et al.
Pageof 81

Showing results (781-790 of 803) with videos related to

Sort By:
Pageof 81
Journal of Medicinal Chemistry|March 28, 1997
Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonistsW C Patt, J J Edmunds, J T Repine, et al.
Human Molecular Genetics|March 3, 2016
Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophyXin Zhao, Zhihua Feng, Karen K Y Ling, et al.
The Science of the Total Environment|May 1, 2022
Associations between social, biologic, and behavioral factors and biomarkers of oxidative stress during pregnancy: Findings from four ECHO cohortsStephanie M Eick, Sarah Dee Geiger, Akram Alshawabkeh, et al.
Plos One|October 16, 2010
Iridovirus and microsporidian linked to honey bee colony declineJerry J Bromenshenk, Colin B Henderson, Charles H Wick, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 18, 2022
Catchment Profile of Large Cochlear Implant Centers in the United StatesAshley M Nassiri, Meredith A Holcomb, Elizabeth L Perkins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2024
Preclinical studies of gene replacement therapy for CDKL5 deficiency disorderGregory Voronin, Jana Narasimhan, Jamila Gittens, et al.
Chemical Biology & Drug Design|June 22, 2007
Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitorsChad A Van Huis, Christopher F Bigge, Agustin Casimiro-Garcia, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory CytokinesJeremy Luban, Rachel Sattler, Elke Mühlberger, et al.
Virus Research|November 29, 2020
The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokinesJeremy Luban, Rachel A Sattler, Elke Mühlberger, et al.
Chemical Biology & Drug Design|August 9, 2007
The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitorJeffrey T Kohrt, Christopher F Bigge, John W Bryant, et al.
Pageof 81